RT
Showing 26 - 50 of >10,000
T-cell Lymphoma, Virus, Intravenous Injection Trial (Oncolytic Virus Injection(RT-01))
Not yet recruiting
- T-cell Lymphoma
- +2 more
- Oncolytic Virus Injection(RT-01)
- (no location specified)
May 18, 2022
Adult Patients Treated in Study R5459-RT-1944 Who Receive A
Not yet recruiting
- Chronic Kidney Disease (CKD)
- Noninterventional
- (no location specified)
Nov 21, 2022
NSCLC, Non-small Cell Carcinoma, NSCLC Stage I Trial (Stereotactic body radiotherapy, Hypofractionated radiotherapy, Durvalumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- +4 more
- Stereotactic body radiotherapy
- +2 more
- (no location specified)
Jul 5, 2022
Degenerative Mitral Valve Disease Trial in Beijing (RT3D-TEE-guided mitral valve repair)
Recruiting
- Degenerative Mitral Valve Disease
- RT3D-TEE-guided mitral valve repair
-
Beijing, Beijing, ChinaFuwai Hospital,Chinese Academy of Medical Sciences
Oct 26, 2022
PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online
Completed
- Prostate Cancer
- Online MR-guided radiotherapy
- CT-guided radiotherapy
-
Odense, DenmarkOdense University Hospital
Nov 8, 2022
Incorporating Biometric Data for Patients Receiving Concurrent
Not yet recruiting
- Cancer
-
Wilmington, North CarolinaNovant Health Cancer Institute Radiation Oncology
Jul 7, 2023
Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)
Recruiting
- Soft Tissue Sarcoma
- Fluzoparib
- Preoperative moderately fractionated radiotherapay
-
Beijing, Beijing, China
- +1 more
Jul 3, 2023
Prenatal Stress, Pregnancy Related, Complementary Trial in London (PRENAYOGA - prenatal yoga)
Recruiting
- Prenatal Stress
- +2 more
- PRENAYOGA - prenatal yoga
-
London, United KingdomMaurice Wohl Clinical Neuroscience Institute, 5 Cutcombe Rd, Bri
Apr 19, 2023
Acute Hypercapnic Respiratory Failure, Acute Hypoxemic Respiratory Failure Trial (Investigational full-face mask with expiratory
Not yet recruiting
- Acute Hypercapnic Respiratory Failure
- Acute Hypoxemic Respiratory Failure
- Investigational full-face mask with expiratory washout
- +2 more
- (no location specified)
Aug 21, 2023
Central Serous Chorioretinopathy Trial in East Melbourne, Glen Iris (2RT subthreshold nanosecond laser - active, 2RT
Recruiting
- Central Serous Chorioretinopathy
- 2RT subthreshold nanosecond laser - active
- 2RT subthreshold nanosecond laser - sham
-
East Melbourne, Victoria, Australia
- +1 more
Oct 17, 2022
Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(RT-01))
Recruiting
- Advanced Solid Tumor
- Oncolytic Virus Injection(RT-01)
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
May 4, 2022
Oligometastatic Renal Cell Carcinoma Trial in Rome (Pembrolizumab injection plus metastasis directed treatment (surgery or RT),
Not yet recruiting
- Oligometastatic Renal Cell Carcinoma
- Pembrolizumab injection plus metastasis directed treatment (surgery or RT)
- Tumor resection or RT
-
Rome, RM, ItalyFondazione Policlinico Universitario "A. Gemelli" IRCCS
Oct 10, 2022
Recession, Gingival Trial (Laterally Closed Tunnel with CTG, CAF with CTG)
Not yet recruiting
- Recession, Gingival
- Laterally Closed Tunnel with CTG
- CAF with CTG
- (no location specified)
Apr 19, 2023
Gingival Recession Trial in Cairo (Connective tissue graft, Free gingival graft, Non surgical)
Recruiting
- Gingival Recession
- Connective tissue graft
- +2 more
-
Cairo, EgyptFaculty of oral and dental medicine, Misr international universi
Jan 14, 2023
Healthy Volunteer Trial in Prahran (Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI),
Completed
- Healthy Volunteer
- Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)
- Vardenafil Oral Tablet
-
Prahran, Victoria, AustraliaNucleus Network, Burnet Institute
Nov 2, 2022
Substance Use Trial (Standard Screening, Standard Psychoeducation, Standard Brief Negotiated Interview (BNI))
Not yet recruiting
- Substance Use
- Standard Screening
- +7 more
- (no location specified)
Jul 19, 2023
Radiotherapy, Breast Cancer Trial (No PMRT for mastectomy / No regional RT for BCS, PMRT for mastectomy / WBI + Regional RT for
Not yet recruiting
- Radiotherapy
- Breast Cancer
- No PMRT for mastectomy / No regional RT for BCS
- PMRT for mastectomy / WBI + Regional RT for BCS
- (no location specified)
Jun 29, 2022
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2)，Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy， distant lymph node 0.5Gy*4)
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Dec 6, 2022
Glioblastoma Multiforme, Adult Trial (Adaptive, two-phase RT)
Not yet recruiting
- Glioblastoma Multiforme, Adult
- Adaptive, two-phase RT
- (no location specified)
Feb 8, 2023
Muscular Fitness Trial in Valencia (RT Functional HIIT circuit program (15 minutes) with or without gamification approach)
Not yet recruiting
- Muscular Fitness
- RT Functional HIIT circuit program (15 minutes) with or without gamification approach
-
Valencia, SpainUniversitat de València
Nov 24, 2023
Non-Hodgkin Lymphoma Trial in Dallas (Focal radiation therapy (RT))
Recruiting
- Non-Hodgkin Lymphoma
- Focal radiation therapy (RT)
-
Dallas, TexasUT Southwestern Medical Center
Jul 8, 2022
Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary
Recruiting
- Breast Cancer
- +2 more
- Systemic therapy for 12 weeks after primary registration
- +3 more
-
Tokyo, JapanTokyo Medical and Dental Univetsity
Nov 15, 2023
Head and Neck Squamous Cell Carcinoma Trial (MRI)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- MRI
- (no location specified)
Jun 21, 2023
High Grade Glioma Trial in Cleveland (procedure, radiation, drug)
Recruiting
- High Grade Glioma
- LITT
- +2 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jan 5, 2023
Solid Tumor, Advanced Cancer Trial in Wuxi (Oncolytic Virus Injection(RT-01))
Recruiting
- Solid Tumor
- Advanced Cancer
- Oncolytic Virus Injection(RT-01)
-
Wuxi, Jiangsu, ChinaWuxi People's Hospital
Jan 19, 2022